TY - JOUR T1 - Global Lung Initiative equations in pulmonary hypertension screening in systemic sclerosis JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00528-2018 SP - 1800528 AU - Thibaud Soumagne AU - Alicia Guillien AU - Arnaud Chambellan AU - Thông Hua-Huy AU - Anh Tuan Dinh-Xuan AU - Bruno Degano Y1 - 2018/01/01 UR - http://erj.ersjournals.com/content/early/2018/07/12/13993003.00528-2018.abstract N2 - Systemic sclerosis (SSc) is a connective tissue disease characterised by widespread vasculopathy and excessive fibrosis in multiple organs, including the lungs [1]. The most frequent pulmonary involvement in SSc is interstitial lung disease (ILD), but the most harmful is pulmonary hypertension (PH), a complication found in about 10% of SSc patients [2]. In patients with SSc, early diagnosis and prompt therapy of PH (either isolated or associated with ILD) are beneficial from a prognostic standpoint, and recommendations for active screening of PH in SSc have therefore been established [3].FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.Conflict of interest: Dr. Soumagne has nothing to disclose.Conflict of interest: Dr. Guillien has nothing to disclose.Conflict of interest: Dr. Chambellan has nothing to disclose.Conflict of interest: Dr. Hua-Huy has nothing to disclose.Conflict of interest: Dr. Degano has nothing to disclose.Conflict of interest: Dr. Dinh-Xuan has nothing to disclose. ER -